Pentokey Organy
PENTOKEYORGANYLTD NSE
Pentokey Organy
ChemicalsNSE: PENTOKEYORGANYLTD BSE: 524210 Commodity Chemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹22.55 Cr
Volatility
Moderate
P/E Ratio
84.4
EBITDA
₹-0.20 Cr
Return on Equity
2.6%
Debt to Equity
0
Book Value
₹15.45
EPS
₹0.78
52W High
₹57
52W Low
₹28.49
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 4.79% over last 3 years.
- Company has high debtors of 203 days.
Growth Rate
Revenue Growth
60.77% higher than
3Y
Net Income Growth
0% higher than
3Y
Cash Flow Change
-60% lower than
3Y
ROE
-72.49% lower than
3Y
ROCE
-72.48% higher than
3Y
EBITDA Margin (Avg.)
-142% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.3 | 2.07 | 0.03 | 0 | 0 | 0.22 | 0 | 0.61 | 5.06 | 0.98 | -2.09 | 2.09 | 0 |
| Expenses | 1.97 | 1.82 | 0.1 | 0.07 | 0.08 | 0.26 | 0.06 | 0.63 | 4.62 | 0.95 | -1.71 | 2.3 | -0.14 |
| Operating Profit | 0.33 | 0.25 | -0.07 | -0.07 | -0.08 | -0.04 | -0.06 | -0.02 | 0.44 | 0.03 | -0.38 | -0.21 | 0.14 |
| OPM % | 14.35% | 12.08% | -233.33% | — | — | -18.18% | — | -3.28% | 8.7% | 3.06% | — | -10.05% | — |
| Other Income | 0.11 | 0.11 | 0.11 | 0.12 | 0.13 | 0.15 | 0.1 | 0.08 | 0.04 | 0.11 | 0.09 | 0.41 | 0.08 |
| Interest | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.43 | 0.36 | 0.04 | 0.05 | 0.05 | 0.11 | 0.04 | 0.06 | 0.48 | 0.14 | -0.29 | 0.2 | 0.22 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.43 | 0.36 | 0.04 | 0.05 | 0.05 | 0.11 | 0.04 | 0.06 | 0.48 | 0.14 | -0.29 | 0.2 | 0.22 |
| EPS in Rs | 0.69 | 0.57 | 0.06 | 0.08 | 0.08 | 0.18 | 0.06 | 0.1 | 0.77 | 0.22 | -0.46 | 0.32 | 0.35 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 122 | 85.44 | 0.76 | 4.7 | 9.29 | 1.56 | 0 | 0 | 4.37 | 4.4 | 0.83 | 2.09 | 0.98 |
| Expenses | 122 | 88.66 | 2.59 | 5.31 | 10.1 | 2.25 | 0.54 | 0.41 | 3.52 | 3.96 | 1.04 | 2.3 | 1.4 |
| Operating Profit | -0.75 | -3.22 | -1.83 | -0.61 | -0.81 | -0.69 | -0.54 | -0.41 | 0.85 | 0.44 | -0.21 | -0.21 | -0.42 |
| OPM % | -0.62% | -3.77% | -240.79% | -12.98% | -8.72% | -44.23% | — | — | 19.45% | 10% | -25.3% | -10.05% | -42.86% |
| Other Income | 0.4 | 0.25 | 14.79 | 0.98 | 1.17 | 0.25 | 0.3 | 0.25 | 2.36 | 0.45 | 0.46 | 0.41 | 0.69 |
| Interest | 3.46 | 3.7 | 2.19 | 0.26 | 0.05 | 0 | 0 | 0 | 0.03 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.59 | 0.62 | 0.63 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -4.4 | -7.29 | 10.14 | 0.05 | 0.31 | -0.44 | -0.24 | -0.16 | 3.18 | 0.88 | 0.25 | 0.2 | 0.27 |
| Tax % | 0% | 22.5% | 5.23% | 80% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -4.4 | -8.94 | 9.61 | 0.01 | 0.31 | -0.44 | -0.24 | -0.16 | 3.18 | 0.88 | 0.25 | 0.2 | 0.27 |
| EPS in Rs | -7.01 | -14.25 | 15.32 | 0.02 | 0.49 | -0.7 | -0.38 | -0.26 | 5.07 | 1.4 | 0.4 | 0.32 | 0.43 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 |
| Reserves | -1.25 | -10.18 | -0.57 | -0.55 | -0.23 | -0.68 | -0.91 | -1.07 | 2.11 | 2.99 | 3.18 | 3.42 |
| Borrowings | 27.28 | 17.99 | 6.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 |
| Other Liabilities | 18.03 | 6.99 | 3.65 | 0.47 | 0.88 | 0.49 | 0.15 | 0.05 | 0.54 | 0.24 | 0.34 | -0.24 |
| Total Liabilities | 50.33 | 21.07 | 15.85 | 6.19 | 6.92 | 6.08 | 5.51 | 5.25 | 8.92 | 9.5 | 9.79 | 9.44 |
| Fixed Assets | 9.41 | 10.36 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| CWIP | 0.55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 1.24 | 1.27 |
| Other Assets | 40.37 | 10.71 | 15.73 | 6.17 | 6.89 | 6.06 | 5.48 | 5.22 | 8.89 | 9.46 | 8.55 | 8.17 |
| Total Assets | 50.33 | 21.07 | 15.85 | 6.19 | 6.92 | 6.08 | 5.51 | 5.25 | 8.92 | 9.5 | 9.79 | 9.44 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.08 | 12.43 | -2.99 | 8.31 | -1.95 | 0.86 | 0.56 | -0.42 | -0.1 | 0.55 | 0.22 | 0.76 |
| Investing | 0.49 | -0.19 | 15.92 | -0.61 | 1.7 | -0.89 | -0.55 | 0.23 | 0.19 | -0.59 | -0.21 | 1.45 |
| Financing | -0.7 | -12.42 | -13.16 | -7.29 | -0.01 | 0 | 0 | 0 | -0.03 | -0.01 | 0 | 0 |
| Net Cash Flow | -0.13 | -0.17 | -0.23 | 0.42 | -0.25 | -0.03 | 0.01 | -0.19 | 0.06 | -0.04 | 0.01 | 2.21 |
| Free Cash Flow | -0.52 | 11.13 | 12.93 | 9.21 | 0.48 | 0.86 | 0.56 | -0.42 | -0.1 | 0.55 | 0.22 | 0.76 |
| CFO/OP | -11 | -386 | 154 | -1,426 | 238 | -128 | -100 | 98 | -13 | 127 | -124 | -343 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26.57 | 0.81 | 0 | 15.53 | 86.44 | 225 | — | — | 12.53 | 157 | 128 | 203 |
| Inventory Days | 50.84 | 2.19 | 93.37 | 6.77 | 11.1 | 0 | — | — | 23.95 | 0 | 167 | 62.41 |
| Days Payable | 54.11 | 16.31 | 492 | 22.87 | 26.95 | — | — | — | 45.62 | — | 65.9 | -51.06 |
| Cash Conversion Cycle | 23.3 | -13.31 | -399 | -0.56 | 70.58 | 225 | — | — | -9.14 | 157 | 229 | 316 |
| Working Capital Days | 4.47 | -17 | 5,249 | 227 | 122 | 299 | — | — | 284 | 270 | 1,245 | 375 |
| ROCE % | -2.82% | -15.83% | -16.44% | -5.47% | -10.37% | -7.57% | -4.38% | -3.03% | 47.28% | 10.09% | 2.67% | 2.09% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Pentokey Organy insights
62 extracted metrics + investor summaries across FY10–FY26.
Documents
1
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Submitted Regulation 74(5) depository certificate for quarter ended 31 March 2026. 15 Apr - Submitted Regulation 74(5) depository certificate for quarter ended 31 March 2026.
2
Closure of Trading Window
26 Mar - Trading window closed from 1 April 2026 until 48 hours after Q4 2026 unaudited results become public. 26 Mar - Trading window closed from 1 April 2026 until 48 hours after Q4 2026 unaudited results become public.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
14h - Publication of Public Notice by the Company 14h - Publication of Public Notice by the Company
4
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Feb - Publication of Extract of Unaudited Results for the quarter ended 31st December 2025 on Newspaper 13 Feb - Publication of Extract of Unaudited Results for the quarter ended 31st December 2025 on Newspaper
5
Board Meeting Outcome for Outcome Of The Board Meeting-Unaudited Quarterly Results For The Quarter Ended 31St December 2025
12 Feb - Board approved Q3 FY26 results: Q3 revenue Rs13,085.02L; Q3 loss Rs55.42L; nine-month profit Rs2,386.62L. 12 Feb - Board approved Q3 FY26 results: Q3 revenue Rs13,085.02L; Q3 loss Rs55.42L; nine-month profit Rs2,386.62L.
Frequently Asked Questions about Pentokey Organy
What does Pentokey Organy (India) Ltd do?
Incorporated in 1986, Pentokey Organy (India) Ltd trades pharmaceutical products.[1]
Where is Pentokey Organy (India) Ltd (524210) listed?
Pentokey Organy (India) Ltd trades as PENTOKEYORGANYLTD on the NSE and under code 524210 on the BSE.
Which sector does Pentokey Organy (India) Ltd belong to?
Pentokey Organy (India) Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Pentokey Organy (India) Ltd?
Pentokey Organy (India) Ltd has a market capitalisation of ₹22.55 Cr, which places it in the Small Cap band.
What is the PE ratio of Pentokey Organy (India) Ltd?
Pentokey Organy (India) Ltd trades at a PE ratio of 84.40, on earnings per share of ₹0.78, against a book value of ₹15.45 per share.
What is the 52-week high and low of Pentokey Organy (India) Ltd?
Over the last 52 weeks Pentokey Organy (India) Ltd has traded between ₹28.49 and ₹57.
What is the Return on Equity (ROE) of Pentokey Organy (India) Ltd?
Pentokey Organy (India) Ltd reported a return on equity of 2.60%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 1986, Pentokey Organy (India) Ltd trades pharmaceutical products.[1]
Website pentokey.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524210.md for Pentokey Organy (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.